(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...

Most states allow some form of "medical marijuana." It is especially popular with pain patients, many of whom do not have ...

No serious side effects or discomfort observed Final safety and absorption data expected in March 2025 SARASOTA, FL, Feb. 11, ...

New research on the use of medical marijuana for pain finds that it was “comparatively more effective than prescription medications” for treating chronic pain after a three-month period, and that many ...

Globus will buy all outstanding Nevro shares for $5.85 per share under the terms of the agreement, therefore reflecting a 27% ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Patients at WWL are experiencing life-changing care for the treatment of osteoarthritis and chronic knee-pain by using the Apos® device, a NICE recommended clinical innovation that is supported by the ...

The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...

Introduction: Chronic pain is defined as pain lasting longer than 3 months. This often causes persistent emotional distress and functional disability that is refractory to conventional treatments.

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Hip pain affects countless women but is often overlooked by doctors Understanding its causes and solutions can lead to ...

SARASOTA, FL - Silo Pharma , Inc. (NASDAQ:SILO), a $6.91 million market cap biopharmaceutical company currently trading at $1.54 per share, has announced promising preliminary results from a study on ...